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Apoptosis-inducing factor (Aif) is a ubiquitously 
expressed flavoprotein with NADH oxidase 
activity located in the mitochondrial inter-
membrane space (Candé et al., 2002). In mito-
chondria, Aif appears to be important in 
regulating oxidative phosphorylation and re-
active oxygen species (ROS) levels to mediate 
antiapoptotic functions in vivo, as shown by 
studies with tissue-specific Aif deficiency (Joza 
et al., 2005; Pospisilik et al., 2007; Ishimura et al., 
2008) with the harlequin (Hq) strain of mice, 
which have a proviral insertion in the upstream 
regulatory region of the aif gene leading to 
Aif hypomorphism (Klein et al., 2002), and with 
the identification of a human Aif-associated 
myopathy (Ghezzi et al., 2010). However, when 
released from mitochondria upon activation 
of intrinsic death pathways, Aif can cause nuclear 
DNA degradation, a proapoptotic function pos-
sibly critical for embryonic development (Joza 
et al., 2001). Curiously, in many of these ex-
amples, Aif deficiency appears to have tissue- 
and cell lineage–specific effects despite the 
ubiquitous nature of Aif expression. Although 
there is both indirect (Ferri et al., 2000; Bidère 
and Senik, 2001) and direct (Srivastava et al., 
2007) evidence that Aif participates in death 
pathways in peripheral T cells, it is not yet clear 
if there are in vivo consequences of such 
roles in T cell development.
T lineage cells undergo extensive prolifera-
tion and death at multiple points during intra-
thymic development, starting from the early 
CD4CD8 (double-negative; DN) stages. 
DN cells with nonproductively rearranged 
TCR- loci undergo neglect-induced death 
(NID) via mitochondrial pathways (Strasser 
and Bouillet, 2003). Cells that successfully express 
TCR- enter a pre-TCR–induced program of 
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Apoptosis-inducing factor (Aif) is a mitochondrial flavoprotein that regulates cell metabo-
lism and survival in many tissues. We report that aif-hypomorphic harlequin (Hq) mice 
show thymic hypocellularity and a cell-autonomous thymocyte developmental block associ-
ated with apoptosis at the -selection stage, independent of T cell receptor  recombina-
tion. No abnormalities are observed in the B cell lineage. Transgenes encoding wild-type or 
DNA-binding–deficient mutant Aif rectify the thymic defect, but a transgene encoding 
oxidoreductase activity–deficient mutant Aif does not. The Hq thymic block is reversed  
in vivo by antioxidant treatment, and Hq T but not B lineage cells show enhanced oxidative 
stress. Thus, Aif, a ubiquitous protein, serves a lineage-specific nonredundant antiapoptotic 
role in the T cell lineage by regulating reactive oxygen species during thymic -selection.
© 2012 Banerjee et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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proliferation and differentiation, leading to their entry into 
the CD44CD25 (DN4) and thence into the CD4+CD8+ 
(double-positive; DP) stage via the process of -selection 
(Hoffman et al., 1996). Survival during -selection depends 
on several factors, ranging from IL-7–IL-7R interactions 
(Trigueros et al., 2003) and adenosine deaminase–mediated 
ATP clearance (Van De Wiele et al., 2002; Thompson et al., 
2003) to the availability of the small GTPase Rho (Cleverley 
et al., 1999; Costello et al., 2000) and the death protein PD-1 
(Nishimura et al., 2000). DP cells productively rearranging 
their TCR- loci but failing positive selection die, possibly by 
yet another form of NID controlled by the nuclear retinoic 
acid–related orphan receptor  (Sun et al., 2000). Interestingly, 
the broad-spectrum caspase inhibitor protein baculovirus p35 
has been reported to leave thymic selection unaffected, 
although a contrary finding has been reported as well (Izquierdo 
et al., 1999; Doerfler et al., 2000). It is thus possible that 
multiple interacting death pathways are involved during 
early thymocyte development and that some of these may 
be caspase independent.
On this background, we have investigated the Hq mouse 
strain, which shows a 5–10-fold reduction in Aif expression 
levels (Klein et al., 2002), for a potential T cell lineage–specific 
developmental role for Aif, and we show that Aif expression 
in T lineage cells and its function in regulating ROS levels is 
critical for their successful transition through -selection.
RESULTS
Aif hypomorphic Hq mice show a naive T cell deficit  
in the periphery
There was a substantial reduction in the frequency of both 
CD4 and CD8 T cells in the spleen and lymph nodes of 
8–12-wk-old Hq mice (Fig. 1 A). Although the absolute total 
cell numbers in spleen and LN were not consistently different 
between WT and Hq mice, frequencies (Fig. 1 B) and abso-
lute numbers of CD4 and CD8 cells were significantly low 
(Fig. 1, C and D). This was specific to the T cell compart-
ment because the numbers of either macrophages or B cells 
showed little or no difference (Fig. 1 E). This T cell–specific 
attrition was more prominent in the phenotypically naive 
CD44low population as compared with the CD44high effector/ 
memory population (Fig. 1, F and G).
Hq mice have a T lineage cell-autonomous thymic 
developmental blockade
We therefore explored the possibility that Aif deficiency had 
an effect on T lineage cell development in the thymus. In 
8–12-wk-old mice, the Hq thymus was significantly hypo-
cellular compared with the WT thymus, and the difference was 
most prominent in the CD4CD8+ single-positive (SP; CD8SP), 
CD4+CD8 CD4SP, and DP cells but was less marked in the 
DN cells (Fig. 2, A and B). However, / T cell numbers were 
not reduced in the Hq thymus (/ cells/thymus [mean + SE]: 
0.75 × 106 + 0.35 [WT], 1.7 × 106 + 0.53 [Hq]; P > 0.1).
We next tested whether a relative lack of Aif specifically in 
T lineage cells and/or in thymic stromal cells was required for 
Figure 1. Deficit of naive T cells in the peripheral lymphoid organs 
of Aif-hypomorphic Hq mice. (A) Representative two-color analyses of 
splenic and lymph node cells from 8–12-wk-old WT and Hq mice stained 
for CD4 and CD8, showing frequencies of cells in quadrants. (B–D) Fre-
quencies (B) and absolute numbers of CD4 and CD8 cells in the spleen  
(C) and inguinal lymph node (D) of WT and Hq mice. *, P < 0.01. (E) Abso-
lute numbers of B220+ B cells (B) and CD11b+ macrophages (M) in the 
spleen (S) and inguinal lymph node (LN) of WT and Hq mice. (F) Represen-
tative analysis of CD44 levels on gated CD4 or CD8 cells from spleen or 
lymph nodes of WT (thin lines) or Hq (thick lines) mice. Filled histograms 
represent isotype controls. (G) Absolute numbers of CD44lo (naive) and 
CD44hi (memory) CD4 and CD8 cells per organ in the spleen (S) and ingui-
nal lymph nodes (LN) of WT and Hq mice. *, P < 0.01; **, P < 0.05. All data 
are shown as mean ± SE (n = 3–5) and are representative of at least three 
independent experiments.
o
n
 February 2, 2017
D
ow
nloaded from
 
Published August 6, 2012
JEM Vol. 209, No. 9 
Article
1643
Hq lineage cells to the DN compartment 
was equivalent, the Hq contribution de-
clined notably in the succeeding DP and 
SP compartments (Fig. 2, D and F). These 
chimera-based data suggested that a relative 
lack of Aif specifically affects T lineage cells 
in cell-autonomous fashion and leads 
to attrition beyond the DN thymocyte 
stage in vivo.
The thymic defect in Hq mice is most prominent  
at the -selection stage
Within the DN thymocyte compartment, subpopulations as 
defined by their CD25/CD44 expression phenotype showed 
alterations in Hq thymi, most notably with reduced frequency 
of CD44+CD25 DN1 cells, increased frequency of the 
CD44CD25+ DN3 stage cells, and reduced frequency of 
the CD44CD25 DN4 population (Fig. 3, A and B). The 
transition from CD27DN3 to CD27+DN3 stages, which 
accompanies successful entry into -selection (Taghon et al., 
2006), was also poor in Hq mice (Fig. 3, C and D).
We also tested Hq thymocytes in vitro by using the 
OP9DL1 stromal cell line expressing the Notch-1 ligand 
the developmental alterations seen in Hq mice. For this, we 
made parent-F1 mixed bone marrow chimeras in which 
irradiated recipient mice were reconstituted with a mixture 
of bone marrow cells from CD45.1+ WT and CD45.2+ WT 
or Hq mice. Upon reconstitution, Hq donor marrow recon-
stituted CD4 and CD8 T cells in peripheral blood and lymph 
nodes very poorly, whereas this deficit was far less prominent 
in B cells, macrophages, and granulocytes (Fig. 2, C and E). 
Similarly, B220+ B lineage cells and Gr-1+ granulocytic lineage 
cells in the bone marrow of these chimeric mice showed little 
difference in the ability of WT and Hq donors to repopulate 
these compartments (Fig. 2 D). In the thymus of these mixed 
marrow chimeric mice, although the contribution of WT and 
Figure 2. Thymus-specific T cell lineage–
autonomous developmental blockade in Hq 
mice. (A) Representative analysis of thymocytes 
from 8–12-wk-old WT and Hq mice stained for 
CD4 and CD8, showing frequencies of cells in 
quadrants. Data are representative of three inde-
pendent experiments. (B) Numbers of thymocyte 
subpopulations per thymus in WT and Hq mice, as 
mean ± SE (n = 4). *, P < 0.01. (C–F) Mixed bone 
marrow chimeric mice were constructed by giving 
CD45.1xCD45.2 F1 recipients WT CD45.1 bone 
marrow in a 1:1 ratio with CD45.2 WT or Hq mar-
row (as indicated). Chimeric mice were analyzed at 
4–8 wk for the distribution of CD45 allotypes in 
various cell lineages in different tissues. Cells from 
chimeric mice were stained for donor CD45 allo-
types and various lineage markers. Representative 
two-color plots are shown for peripheral blood 
cells stained for CD45 allotypes versus B220, 
CD11b, Gr-1, CD4, or CD8 (C), and bone marrow 
cells stained for CD45 allotypes versus B220 and 
Gr-1 and thymocytes stained for CD45 allotypes 
versus CD4 and CD8 (D). Frequencies of cells in 
each quadrant are indicated. Absolute numbers  
of lymph node CD4, CD8, B220, or CD11b cells  
(E) and of thymocyte DN, DP, CD4SP, and CD8SP sub-
sets (F) of either CD45.1+ or CD45.2+ phenotype 
from the chimeric mice receiving either WT or Hq 
bone marrow as described. The groups shown are 
CD45.1 (WT donor) from chimeras given CD45.2 
WT (CD45.1WT[WT]) or CD45.2 Hq (CD45.1WT[Hq]) 
marrow, and the CD45.2 cells from these chimeras 
(identified as CD45.2WT and CD45.2Hq). Data are 
shown as mean ± SE (n = 3). *, P < 0.01. Data are 
representative of five independent experiments.
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during the stage of -selection during the transition to the 
DN4 and subsequent DP stages, with no corresponding 
defect at comparable stages of B cell development.
The Hq thymic defect is independent of TCR- recombination 
and is associated with cell death during -selection
We next tested if the major developmental checkpoint, namely, 
successful pre-TCR formation which initiates -selection 
(Michie and Zúñiga-Pflücker, 2002), was compromised in 
Hq mice. Intracellular TCR-–expressing DN3 cells from 
WT and Hq thymus showed equivalent frequencies (Fig. 4, 
A and B). We then directly tested if the Hq defect was de-
pendent on impaired tcrb recombination by breeding the Hq 
mice with DO11.10-TCR transgenic (tg) mice to generate 
Aif hypomorphic mice expressing already recombined TCR- 
and TCR- chains. Hq-DO11.10 mice so generated continued 
to show thymic hypocellularity (Fig. 4 C). Thus, the data so far 
indicated that Aif hypomorphism led to a specific failure of 
-selection independent of pre-TCR formation.
We next examined proliferation and cell death during 
-selection. The frequencies of actively cycling cells in the 
DN3 and DN4 compartments, as detected by the in vivo 
incorporation of a pulse of 5-ethynyl-2-deoxyuridine (EdU), 
were lower in Hq than in WT mice (Fig. 4, D and E). 
Also, Hq DN4 cells were smaller than those in WT mice 
(Fig. 4 D). Furthermore, DN cells in the Hq thymus showed 
significantly higher frequencies of annexin V–binding apoptotic 
Delta-1, which has been shown to support the development 
of the T cell lineage from undifferentiated precursors (Schmitt 
and Zúñiga-Pflücker, 2002; Schmitt et al., 2004). Early pre-
cursor thymocytes were purified from WT or Hq thymus by 
sorting, first by depletion of CD4+, CD8+, CD3+, B220+, 
Gr-1+, CD11b+ and CD11c+, NK1.1+, and TCR-/+ cells, 
followed by positive selection to purify CD44+ cells, to 
provide a starting population consisting of DN1, DN2, and 
early thymic precursors. The purity obtained for this popula-
tion was >90%. These early thymocytes were cultured with 
OP9DL1 monolayers in the presence of IL-7 and Flt3L as 
previously described (Schmitt and Zúñiga-Pflücker, 2002). 
On day 3 of culture, Thy-1+CD44 cells were gated as the 
population that had undergone T cell lineage developmental 
progress and examined for the expression of CD25 to esti-
mate the transition from the DN3 (CD25+) to the DN4 
(CD25) stage. It was evident that the Hq Thy-1+CD44 
thymocytes had a far greater proportion of CD25+ DN3 cells 
than did the WT cells (Fig. 3, E and G). No cells had reached 
DP stage maturation at this point.
However, the B cell lineage in Hq mice appeared normal. 
In addition to normal peripheral B cell numbers (Fig. 1 F), the 
developmental stages of the B cell lineage in the bone marrow 
of Hq mice showed normal frequencies and numbers, particu-
larly at the pro–B-to-pre–B stage transition accompanying heavy 
chain selection, a process analogous to thymic -selection 
(Fig. 3, H and J). Thus, a major thymic defect appears to be 
Figure 3. -Selection stage thymic de-
fect in Hq mice. (A) Representative analysis 
of CD44 and CD25 expression on gated DN 
thymocytes (negative for lineage markers  
CD3/CD4/CD8/B220/CD11b/CD11c/Gr-1) of  
8–12-wk-old WT and Hq mice, showing frequen-
cies of cells in quadrants. (B) Numbers of various 
thymocyte subsets per thymus in WT or Hq 
mice, from analyses as in A, shown as mean ± 
SE (n = 3). *, P < 0.01; **, P < 0.05. (C) Repre-
sentative analysis of gated DN3 thymocytes 
from WT (thin line) or Hq (thick line) stained 
for CD27. Gray curve indicates isotype control. 
(D) Frequencies of CD27lo and CD27hi DN3 
thymocytes from WT and Hq mice as indicated, 
from analyses as in C, shown as mean ± SE  
(n = 3). *, P < 0.01. (E–G) Magnetically sorted 
>90% pure DN1 + DN2 thymocytes from WT 
or Hq thymus were put in culture with the 
OP9DL1 stromal cell line. Cells were harvested 
and analyzed flow cytometrically on day 3 of 
culture. Two-color plots (E) show the expres-
sion profile of Thy-1 and CD44 on cells from 
WT or Hq cultures as indicated. Flow cytomet-
ric histograms (F) show the CD25 expression profile of gated Thy-1+CD44 cells from WT (thin line) or Hq (thick line) cultures. Bar diagrams (G) show 
frequencies of DN3 (CD44CD25+) and DN4 (CD44CD25) cells in the Thy-1+CD44 compartment of WT or Hq cultures as mean ± SE (n = 3). *, P < 0.05. 
(H) B220 staining on bone marrow cells from WT (thin line) or Hq (thick line) mice. Filled histogram represents isotype control. (I) Representative two-
color analysis of gated B220+ bone marrow cells from WT or Hq mice, stained for CD43 and IgM, showing frequencies of pro–B (CD43+IgM), pre–B 
(CD43IgM), and B (CD43IgM+) cells. (J) Numbers of B cell lineage subsets in bone marrow of WT or Hq mice, from analyses in H and I, shown as mean ± 
SE (n = 3). Data are representative of at least two independent experiments.
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cells than those in the WT thymus (Fig. 4 F). DN3 and DN4 
stage cells both showed evidence of greater annexin V–binding 
apoptotic cells in Hq than in WT thymi (Fig. 4 G), whereas 
the frequency of apoptotic cells was not significantly different 
in DP thymocytes of WT and Hq mice (Fig. 4 H). Further-
more, when DN1, DN3, and DN4 thymocytes were purified 
by electronic sorting and cultured for up to 16 h, DN3 and DN4 
cells from Hq thymi showed higher frequencies of cell death 
(Fig. 4 I). Although DN1 thymocyte frequencies were reduced 
in Hq mice, DN1 thymocytes from WT and Hq mice showed 
comparable death in cultures in vitro (Fig. 4 I). Together, 
these data suggest a specific and prominent intrathymic defect 
in Hq mice at the -selection stage associated with enhanced 
cell death.
T cell developmental defect in Aif-hypomorphic mice  
is corrected by tg Aif
If the thymic defect we have observed in Hq mice was 
truly a consequence of Aif hypomorphism, then provision 
of additional Aif in the Hq background should correct the 
defect. For testing this, we generated tg mice that express 
Aif using a heterologous promoter (Fig. 5 A). According to 
the testicular transgenesis protocol reported earlier (Dhup 
and Majumdar, 2008), we injected linearized plasmid DNA 
intratesticularly in FVB/J male mice followed by electro-
poration in vivo. The male mice were then bred with FVB/J 
females to obtain tg progeny (Fig. 5 B). Independent founder 
lines were obtained. Transgene-bearing male founder mice 
were then bred with heterozygous Hq females to gener-
ate male littermates of all four genotypes, namely, non-tg 
WT, non-tg Hq, tg WT, and tg Hq. Both the transgene 
and Hq status were confirmed by genotyping PCRs. West-
ern blot analysis of splenic cells from the four genotypes 
showed that the tg Hq mice had enhanced levels of Aif, al-
though they were still not comparable to the non-tg WT 
mice (Fig. 5 C).
We next compared the T cell lineage phenotype in litter-
mate mice of the four genotypes identified in the previous 
paragraph. The additional expression of tg Aif in WT mice 
did not have any detectable effect in any of the readouts used. In 
the spleen, the reduced frequencies of CD4 and CD8 T cells, 
and even more specifically of naive CD44lo cells, found in 
Hq mice were increased in the tg Hq mice (Fig. 5, D and E). 
Similarly, the thymic hypocellularity found in Hq mice was 
significantly corrected in tg Hq mice (Fig. 5 F). The high DN 
thymocyte frequency found in Hq mice was reduced in the 
tg Hq mice (Fig. 5 G), and the altered frequencies of DN3 
and DN4 cells, as well as the smaller size of DN4 cells, were 
Figure 4. Hq thymic defect is independent of TCR- recombina-
tion and associated with cell death during -selection. (A) Repre-
sentative histogram overlay of gated DN3 thymocytes from WT (thin 
line) or Hq (thick line) mice, stained for intracellular TCR-. Filled histo-
gram represents isotype control. (B) Frequencies of intracellular TCR- 
containing DN3 thymocytes in WT and Hq mice as calculated from the 
analysis shown in A. Data are shown as mean ± SE (n = 3). (C) Total 
thymocyte numbers in 4–6-wk-old F2 progeny littermate mice from Hq 
and DO11.10-TCR tg parentage. F1 mice generated from Hq × DO11.10 
breeding were intercrossed. The resultant progeny were typed for the 
Hq allele and the TCR transgene and separated into four groups on that 
basis as shown. Data are shown as mean ± SE (n = 3–4). *, P < 0.01.  
(D) Representative histogram overlays of gated DN3 and DN4 thymo-
cytes from WT (thin line) or Hq (thick line) mice given EdU in vivo and 
stained for EdU incorporation. Both EdU staining and cell size (FSC) are 
shown. Filled histograms represent isotype controls. (E) Frequencies of 
DN3 and DN4 thymocytes incorporating EdU in vivo in WT and Hq mice 
as calculated from the analysis shown in D. Data are shown as mean ± 
SE (n = 3). *, P < 0.01. (F) Annexin V staining on gated DN thymocytes 
from WT (thin line) or Hq (thick line) mice. Filled histogram represents 
isotype control. (G) Frequencies of annexin V–binding DN3 and DN4 
thymocytes in WT and Hq mice. Data are shown as mean ± SE (n = 4).  
*, P < 0.01. (H) Frequencies of annexin V–binding DP thymocytes in WT 
and Hq mice. Data are shown as mean ± SE (n = 3). (I) DN1, DN3, and 
DN4 thymocytes from WT or Hq mice as indicated were electronically 
sorted and put in culture in vitro. After varying periods of time as 
shown, the frequencies of dead cells were estimated by Trypan blue 
staining. Data are shown as mean ± SE (n = 3). *, P < 0.05. Data are 
representative of at least three independent experiments.
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the WT aif gene by site-directed mutagenesis and then gen-
erated tg mice that express these mutant Aif versions using 
the same heterologous promoter and testicular transgenesis 
protocol used in the previous section. tg progeny thus ob-
tained were bred as described with heterozygous Hq females 
to generate male littermates of all four genotypes, namely, 
non-tg WT, non-tg Hq, tg WT, and tg Hq, for both mutant 
Aif molecules, namely, the Aif254/264 and the Aif262/299. 
Both the tg and Hq status were confirmed by genotyping 
PCRs. Western blot analysis of splenic cells showed that the 
tg-Hq mice had significant levels of Aif in both Aif254/264 
tg and Aif262/299 tg mice, and the two transgenes did not 
show any notable differences in their expression levels (Fig. 6 A). 
Once again, as with the nonmutated Aif transgene shown in 
Fig. 5, the levels of transgene expression did not match the 
levels of endogenous Aif expression in non-tg WT mice.
We next compared the T cell lineage phenotype in lit-
termate mice of the four genotypes identified for both 
also substantively corrected in tg Hq mice (Fig. 5, H and K). 
Thus, an increase in the level of Aif per cell was sufficient to 
reverse the thymic defect in Hq mice.
Aif mediates its role in the thymus through  
its oxidoreductase function not its DNA-binding function
Aif is known to have a DNA-binding function essential for 
its proapoptotic activity (Ye et al., 2002), but it also has an 
oxidoreductase function that may be involved in its ability to 
regulate mitochondrial function, cell metabolism, and oxida-
tive stress (Sevrioukova, 2011). Distinct point mutations in 
the mouse Aif protein selectively abrogate either the DNA-
binding or the oxidoreductase function: K254A and R264A 
for abrogation of DNA-binding and T262A and V299A for 
abrogation of oxidoreductase activity (Maté et al., 2002; Ye 
et al., 2002; Urbano et al., 2005). We therefore examined if 
either or both functions were required to correct the Hq 
thymic defect. We generated these point mutant genes from 
Figure 5. Restoration of normal thymic 
development and peripheral T cell phenotype 
in Hq mice by transgenically expressed Aif. 
(A) Plasmid map for the expression vector used 
for generating aif tg mice. (B) PCR results of 
screening for transgene inheritance on genomic 
DNA from ear clip tissue from the progeny of 
male mice receiving intratesticular injection of 
the plasmid shown in A. The vector control (+), a 
WT mouse DNA sample, and five sample progeny 
mouse samples are shown, along with a marker 
lane (M). (C) Western blot analysis of Aif expres-
sion in spleen cell lysates. Transgene-bearing 
male mice were bred with heterozygous Hq fe-
males to generate male littermates of all four 
genotypes, namely, non-tg WT, non-tg Hq, tg 
WT, and tg Hq, as indicated. (D) Representative 
two-color analyses of splenic cells from 6–8-wk-
old WT and Hq mice of either non-tg or tg geno-
types as indicated, stained for CD4 and CD8, 
showing frequencies of CD4 and CD8 cells.  
(E) Representative analysis of CD44 levels on 
gated CD4 or CD8 cells from spleen of WT (black 
lines) or Hq (red lines) mice of either non-tg (thin 
lines) or tg (thick lines) genotypes as shown. 
Filled histograms represent isotype controls.  
(F) Numbers of total thymocytes per thymus in 
6–8-wk-old WT and Hq mice of either non-tg or 
tg genotypes as indicated, as mean ± SE (n = 3). 
*, P < 0.01. (G) Representative analysis of thymo-
cytes from WT and Hq mice of either non-tg or 
tg genotypes as indicated, stained for CD4 and 
CD8, showing frequencies of subpopulations.  
(H) Representative analysis of CD44 and CD25 
expression on gated DN thymocytes (negative for 
lineage markers CD3/CD4/CD8/B220/CD11b/
CD11c/Gr-1) of WT and Hq mice of either non-tg or tg genotypes as indicated, showing frequencies of DN thymocyte subpopulations. (I–K) Frequencies 
of DN3 (I) and DN4 (J) thymocyte subsets, and mean size (as mean fluorescence intensity [MFI]) of DN4 thymocytes (K) from WT and Hq mice of either 
non-tg or tg genotypes as indicated, from analyses as in H, shown as mean ± SE (n = 3). *, P < 0.01. All flow cytometric analyses are representative of at 
least two independent experiments.
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frequencies and numbers of naive CD4 and CD8 
T cells found in Hq mice were increased in 
Aif254/264 tg Hq mice but not in Aif262/299 tg Hq 
mice (Fig. 6, B and I), although the recovery seen 
with Aif254/264 was not as complete as that ob-
served with WT Aif (Fig. 5). Similarly, the thymic 
hypocellularity found in Hq mice was significantly 
corrected in Aif254/264 tg Hq mice but not in 
Aif262/299 tg Hq mice (Fig. 6, J and K). The high 
DN thymocyte frequency found in Hq mice was re-
duced (Fig. 6, L and M) and the altered frequencies 
of DN3 and DN4 cells were substantively corrected 
in Aif254/264 tg Hq mice but not in Aif262/299 
tg Hq mice (Fig. 6, N and Q). It remains formally 
possible that higher levels of expression of the 
Aif262/299 transgene would eventually lead to res-
cue of the thymic defect. However, the data do sug-
gest that the oxidoreductase function of Aif may be 
required for maintaining normal thymic develop-
ment, whereas the DNA-binding function is likely 
to be dispensable.
Aif hypomorphism leads to thymic  
hypocellularity through ROS regulation
The possibility of a requirement for the oxidoreductase 
function of Aif in correcting the Hq thymic defect 
indicated that the defect could be a result of ROS stress 
in Aif-hypomorphic thymocytes. We therefore tested 
this in an independent pharmacological approach 
by examining whether treatment with a cell-permeable 
antioxidant that could mimic both superoxide dismutase 
(SOD) and catalase, namely Euk-134 (Doctrow et al., 2002), 
Aif254/264 and Aif262/299. The tg expression of either of 
these Aif mutant proteins in WT mice did not have any detect-
able effect in any of the readouts used. In the spleen, the reduced 
Figure 6. Restoration of normal thymic development and 
peripheral T cell phenotype in Hq mice requires the oxido-
reductase function but not the DNA-binding function of 
Aif. (A) Western blot analysis of Aif expression in spleen cell 
lysates. Mice bearing transgenes encoding the mutant Aif con-
structs Aif254/264 or Aif262/299 were bred with heterozygous 
Hq females to generate male tg WT and tg Hq littermates as 
shown, and spleen cell lysates were tested. (B–E) Frequencies of 
naive CD4 (B and D) and naive CD8 (C and E) cells in spleens 
from 6–8-wk-old WT and Hq littermate mice of either non-tg 
or tg genotypes (with either Aif254/264 or Aif262/299 as indi-
cated) as shown, as mean ± SE (n = 3). *, P < 0.01. (F–I) Num-
bers per spleen of naive CD4 (F and H) and naive CD8 (G and I) 
cells in WT and Hq littermate mice of either non-tg or tg geno-
types (with either Aif254/264 or Aif262/299 as indicated) as 
shown, as mean ± SE (n = 3). *, P < 0.01. (J and K) Numbers of 
thymocytes from 6–8-wk-old WT and Hq littermate mice of 
either non-tg or tg genotypes (with either Aif254/264 or 
Aif262/299 as indicated) as shown, as mean ± SE (n = 3).  
*, P < 0.01. (L–Q) Frequencies of DN (L and M), DN3 (N and O), 
and DN4 (P and Q) thymocytes from WT and Hq littermate  
mice of either non-tg or tg genotypes (with either Aif254/264  
or Aif262/299 as indicated) as shown, as mean ± SE (n = 3).  
*, P < 0.01. All flow cytometric analyses are representative  
of at least two independent experiments.
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transition through -selection, probably by using its cata-
lytic function to control oxidative stress.
We next directly tested if Hq DN thymocytes show 
higher levels of oxidative stress. The peroxide-sensitive dye 
2-7-dichlorofluorescein diacetate (DCFDA) indicated higher 
ROS levels in Hq than in WT DN3 and DN4 cells (Fig. 8 A). 
Consistent with this, Hq DN3 and DN4 thymocytes showed 
lower levels of reduced glutathione, as reflected by lower 
intensities of staining by monochlorobimane (mBCl; Hedley 
and Chow, 1994; Fig. 8 B). However, the superoxide-sensitive 
dye MitoSOX red did not show such a dif-
ference in DN3 and DN4 cells (Fig. 8 C), 
affected the Hq thymic defect in vivo. Young (2 wk old) WT 
and Hq mice were treated daily with Euk-134 or vehicle alone 
for 14 d before the thymic phenotype was determined. Euk-
134 treatment made no discernible difference to WT thymic 
cellularity or subpopulation frequencies, but in Hq mice, 
Euk-134 decreased the DN thymocyte frequency and signifi-
cantly improved total thymic cellularity, particularly that of 
the DP population (Fig. 7, A and B). Euk-134 treatment also 
increased the DN4 frequency in Hq mice (Fig. 7 C). To-
gether, these data indicate that Aif regulates the efficiency of 
Figure 7. Increased ROS levels are involved in the thymic hypocellularity of Hq mice. (A) Representative two-color CD4 versus CD8 analysis of 
thymocytes from WT or Hq mice treated in vivo with Euk-134, as indicated. Frequencies of cells in each quadrant are shown. (B) Absolute numbers per 
thymus of total thymocytes and subsets as indicated in WT and Hq mice treated in vivo with Euk-134. Data are shown as mean ± SE (n = 3–4). *, P < 0.05. 
(C) Frequencies of DN thymocyte subsets as indicated in WT and Hq mice treated in vivo with Euk-134. Data are shown as mean ± SE (n = 3–4). Data are 
representative of three independent experiments.
Figure 8. Increased ROS levels are involved in 
the thymic hypocellularity of Hq mice. (A–C) Rep-
resentative histogram overlays of gated DN3 and DN4 
thymocytes from WT (thin lines) or Hq (thick lines) 
mice stained with DCFDA (A), mBCl (B), or MitoSOX 
red (C) as indicated. Filled histograms represent iso-
type controls. (D) Representative histogram overlays 
of gated DP thymocytes from WT (thin lines) or Hq 
(thick lines) mice stained with DCFDA. Filled histogram 
represents negative control. (E) Representative histo-
gram overlays of gated B220+CD43+IgM pro–B or 
B220+CD43IgM pre–B cells from bone marrow of 
WT (thin lines) or Hq (thick lines) mice stained with 
DCFDA. Filled histograms represent negative controls. 
(F) Representative histogram overlays of gated DN3 
and DN4 thymocytes from WT (thin lines) or Hq (thick 
lines) mice which were non-tg, Aif tg, Aif254/264 tg, 
or Aif262/299 tg as indicated, stained with the ROS 
indicator dye CellROX Deep Red. Filled histograms 
represent negative controls. Data represent three to 
eight independently tested littermate pairs. (G) DN3 
thymocytes from WT or Hq mice as indicated were 
electronically sorted and put in culture in vitro for 8 h 
with () or without (+) Euk-134 as indicated, and the 
frequencies of dead cells were estimated by Trypan 
blue staining. Data are shown as mean ± SE (n = 3)  
*, P < 0.01. All data are representative of at least two 
independent experiments.
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The low frequency of  T cells in the periphery of Hq mice 
is also seen in the mixed bone marrow chimeras. It is specific 
to the T cell lineage because macrophage and B cell develop-
ment does not appear to be drastically affected. Furthermore, it 
is accompanied by notable alterations in thymic development. 
The thymus is hypocellular in Hq mice, and the numbers 
of DP and CD4/CD8SP thymocytes are greatly reduced in 
them. The numbers of DN thymocytes are far less drastically 
reduced. In fact, in some experiments, particularly in younger 
Hq mice, DN thymocyte numbers are comparable between 
Hq and WT mice. These findings are also observed in mixed 
bone marrow chimeras, in which the numbers of DN thymo-
cytes of WT and Hq origin are comparable, whereas the num-
bers of DP thymocytes of Hq origin are drastically lower. 
Thus, Hq mice have a T lineage cell-autonomous defect in 
the DN-DP transition in the thymus.
The cellularity of the thymus, particularly the number of 
DP thymocytes, is significantly controlled by the prolifera-
tion of developing DN thymocytes (Dudley et al., 1994). The 
relevant DN stage subpopulations show significant alterations 
in Hq mice. Although DN1 cell frequencies and numbers are 
reduced, DN3 cell frequencies are increased in Hq mice and 
their numbers are comparable between Hq and WT mice. In 
contrast, DN4 cell frequencies and numbers are reduced in Hq 
mice. In fact, Hq DN3 cells show a poor transition between 
CD27 and CD27+ stages, and CD27 DN3 cell numbers are 
higher in Hq compared with WT mice. Even when DN1+DN2 
thymocytes are put onto OP9-DL1 stromal cells in maturation 
cultures in vitro, the DN3-DN4 transition is poor in Hq cells. 
Thus, a major defect in the Hq thymus appears to become mani-
fest at the point of transition from the DN3 to the DN4 stage.
Two major events are involved in the process of -selection: 
the successful formation of pre-TCRs upon productive 
recombination at the TCR- locus, and the transduction of 
signals through the pre-TCR to induce proliferation as well 
as developmental transition (Wiest et al., 1999; Michie and 
Zúñiga-Pflücker, 2002). The formation of the pre-TCR 
depends on the successful recombination of the TCR- locus 
(Dudley et al., 1994). DN thymocytes from Hq and WT 
mice show comparable frequencies of intracellular TCR- 
protein-expressing cells. Furthermore, the tg provision of an 
already recombined set of TCR genes does not rescue the 
thymic hypocellularity in the Hq genotype. Thus, the thymic 
-selection defect in Hq mice is likely to occur during the 
pre-TCR–driven events of proliferation and differentiation. 
This is supported by the finding that DN3 as well as DN4 
cells in the Hq thymus proliferate poorly. Interestingly, the Hq 
DN4 cells also show a smaller mean size, suggesting that 
many cycling DN4 cells may be dying. In contrast, annexin V–
binding apoptotic cell frequencies are increased in the Hq 
DN3 and DN4 populations, and Hq DN3 and DN4 cells (but 
not DN1 cells) show enhanced cell death in culture in vitro. 
The finding that the / T cell lineage is relatively unaffected 
in Hq mice is also consistent with the possibility that the 
proliferative step in -selection of developing / T cells 
is particularly vulnerable to Aif hypomorphism.
suggesting that Hq thymocytes suffer from peroxide stress. Al-
though DP thymocytes from Hq mice did show an increase 
over WT cells in DCFDA staining levels, this was far more 
modest than in DN3/DN4 cells (Fig. 8 D). Thus, low lev-
els of Aif lead to higher oxidative stress in DN thymocytes. In 
contrast, the closely related B cell lineage does not show any dif-
ferences in ROS levels between Hq and WT bone marrow 
as indicated by DCFDA staining (Fig. 8 E).
A further prediction was that this enhancement of ROS 
levels in non-tg DN3/DN4 Hq thymocytes would no longer 
be seen in thymocytes of Hq mice carrying either the WT 
Aif transgene or the DNA-binding–deficient Aif254/264 
transgene used in Figs. 5 and 6 but would continue to be ap-
parent in the thymocytes of mice carrying the oxidoreductase–
deficient Aif262/299 transgene. Because the transgene contains 
enhanced GFP (eGFP), it was not appropriate to use DCFDA 
to measure ROS levels. We therefore used an alternate ROS-
sensitive dye, CellROX Deep Red, to examine ROS level 
differences in DN3 and DN4 thymocytes of all three tg lines. 
Consistent with the data on rescue of thymic cellularity, the 
WT Aif transgene does indeed abrogate the higher ROS levels 
in DN3 and DN4 thymocytes as does the Aif254/264 mutant 
with abrogated DNA-binding function, whereas the mutant 
Aif262/299 with abrogated oxidoreductase function does not 
do so (Fig. 8 F).
Finally, we tested the prediction that Euk-134, which 
rescues the Hq thymic defect in vivo, provides protection 
from the enhanced cell death seen in Hq DN thymocytes. 
When electronically sorted WT or Hq DN3 and DN4 thymo-
cytes were put in culture with or without Euk-134 for 8 h, the 
enhanced death seen in Hq DN3 and DN4 thymocytes was 
inhibited by Euk-134 (Fig. 8 G).
DISCUSSION
Using the Aif-hypomorphic Hq strain of mice, we have pre-
viously shown major alterations in the sensitivity of activated 
peripheral Hq T cells to both NID and to activation-induced 
cell death in vitro (Srivastava et al., 2007). We now demon-
strate that these mice also show notable changes in the T cell 
compartment in vivo. Specifically, our data indicate that Aif 
hypomorphism in T lineage cells leads to a reduction in the 
efficiency of developmental transition from the DN to the 
DP thymocyte stage, showing that Aif plays a major role in 
regulating the development of T cells.
Hq mice have fewer numbers of peripheral T cells, particu-
larly naive phenotype cells. Curiously, the numbers of CD44hi 
memory phenotype T cells are almost comparable between 
WT and Hq mice. In the absence of functional evidence for the 
memory status of the CD44hi T cells in Hq mice, it remains 
possible that, in a lymphopenic environment in Hq mice, naive 
thymic emigrants would undergo continual homeostatic ex-
pansion, which might alter their CD44 phenotype as has been 
observed in some instances (Cho et al., 2000). Nonetheless, our 
data are consistent with previous indications that impaired NID 
of activated T cells is associated with a preferential survival of 
memory T cells (Hildeman, 2004; Vig et al., 2004).
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SOD/catalase mimic Euk-134. Treatment of Hq mice in vivo 
with this SOD/catalase mimic rescued both the thymic defect 
and the enhanced DN3 and DN4 cell death in vitro, and Hq 
DN thymocytes showed high ROS levels. These high ROS 
levels in Hq mice were abrogated by the WT Aif transgene, as 
well as by the DNA-binding–deficient Aif254/264 transgene, 
but not by the oxidoreductase-deficient Aif262/299 trans-
gene. Thus, Aif-deficient thymocytes are defective in the effi-
ciency of -selection as the result of a failure to handle ROS 
stress leading to enhanced cell death and reduced proliferation.
Curiously, despite the ubiquitous expression of Aif in all cell 
lineages, Aif hypomorphism causes tissue-specific defects (Klein 
et al., 2002). Similarly, because we observe a thymic defect, the 
B cell lineage shows no heavy chain selection defect in Hq 
mice, raising the question of the cell type specificity of this de-
fect because proliferation during heavy chain selection in the 
B cell lineage is as substantial as during thymic -selection 
(Kitamura et al., 1992). Consistent with our model of a con-
nection between ROS stress and tissue defects in Aif hypo-
morphism, B lineage cells in Hq mice show no evidence of 
enhanced ROS stress, suggesting that the T cell lineage, which 
uses ROS for developmental signaling (Ivanov et al., 1993; 
Moon et al., 2004), is more susceptible to the effects of Aif hy-
pomorphism than the B cell lineage is. This may address the 
lineage and tissue specificity of dysfunctional phenotypes ob-
served in mice hypomorphic for a ubiquitously expressed pro-
tein like Aif. The utility and mechanisms for the generation and 
handling of oxidative stress in B versus T lineage cells thus now 
become issues of interest. Finally, our data also raise the ques-
tion of whether this T lineage defect is observed in instances of 
human aif mutations leading to neuromuscular disease (Ghezzi 
et al., 2010) and, if it is, whether it has clinical implications of 
significance to the natural history of the disease.
MATERIALS AND METHODS
Aif constructs. The AIF-expressing plasmids used had a backbone of 
pIRES2-EGFP (Takara Bio Inc.) into which the WT mouse aif cDNA (gift 
from S. Ackerman, The Jackson Laboratory, Bar Harbor, ME) was cloned. 
Two different mutant forms of Aif with point mutations abrogating either 
the DNA-binding or oxidoreductase function were generated in this con-
struct by site-directed mutagenesis. For this purpose, forward and reverse 
primers containing the mutant sequence were designed. Phusion polymerase 
(Thermo Fisher Scientific) with high fidelity and high processivity was used 
to amplify the entire construct using the mutated primers. After amplifica-
tion, WT template strands were digested from the product by DpnI (New 
England Biolabs) and mutant sequence–containing DNA used to transform 
competent Escherichia coli cells. Colonies obtained were screened by sequenc-
ing to determine the presence of the desired mutation. Because each mutant 
required two point mutations, plasmids from the clones positive for the first 
mutation were used for a second round of mutation using appropriate prim-
ers. The mutations induced and the primers used were as follows: Aif254/ 
264, K254A (5-CAGATTACCTTTGAAGCGTGCTTGATTGCAACG-3  
and 5-CGTTGCAATCAAGCACGCTTCAAAGGTAATCTG-3) and R264A 
(5-CGGGAGGCACTCCAGCAAGTCTGTCTGCCATC-3 and 5-GAT-
GGCAGACAGACTTGCTGGAGTGCCTCCCG-3); and Aif262/299, 
T262A (5-GATTGCAACGGGAGGCGCTCCAAGAAGTCTGTCTGC-3  
and 5-GCAGACAGACTTCTTGGAGCGCCTCCCGTTGCAATC-3) 
and V299A (5-GGAGAAGATCTCTCGGGAGGCCAAGTCAATTA-
CAGTTATCG-3 and 5-CGATAACTGTAATTGACTTGGCCTCCC-
GAGAGATCTTCTCC-3).
Although we have used the Hq mouse strain reported to be 
hypomorphic for Aif, it was essential to obtain formal evidence 
that it was the aif hypomorphism that was, in fact, responsible 
for the T cell developmental defect we have observed. Strik-
ingly, when we provide tg WT Aif in the Hq genotype, all 
features of  T cell developmental defect reported here are sub-
stantially rescued, from the peripheral naive T cell numbers to 
the thymic cellularity and the DN3-DN4 thymocyte tran-
sition. Together, our observations therefore support a model 
in which an antiapoptotic function of Aif is required for suc-
cessful survival of pre-TCR–expressing DN3 thymocytes as 
they proliferate and differentiate to the DN4 and DP stages.
What is the possible mechanism of the role of Aif in the 
DN3-DN4-DP progression downstream of the pre-TCR? 
Together, our data suggest that cells undergoing proliferative 
expansion during -selection are dying, leading to reduction 
in the numbers of survivors that make it through to the DP 
stage. The antiapoptotic role of Aif has been very prominent 
in several cell lineages in vivo, from neurons (Ishimura et al., 
2008) and muscle cells (Joza et al., 2005) to  cells in the islets 
of Langerhans (Schulthess et al., 2009). At least in neurons, 
there is reason to believe that Aif hypomorphism leads to 
death during cell cycle (Klein et al., 2002; Ishimura et al., 
2008) and that this is related to alterations in the assembly 
of the mitochondrial oxidative phosphorylation apparatus 
and/or the generation and handling of oxidative stress (Vahsen 
et al., 2004). Although Aif was proposed to be a hydrogen 
peroxide scavenger (Klein et al., 2002), it has many more 
complex roles in mitochondrial functions, many of which 
lead to the generation of oxidative stress in the absence of Aif 
(Vahsen et al., 2004; Cheung et al., 2006; Joza et al., 2009).
The role of the cellular redox status in developing T cells has 
been reported to be a major factor in determining the efficiency 
of T cell development (Ivanov et al., 1993). It is therefore plausi-
ble that a similar susceptibility is created in DN thymocytes 
through similar mechanisms by Aif hypomorphism. The finding 
that / T cell numbers are not altered in Hq mice is consistent 
with this possibility because / selection is known to induce 
much less proliferation than -selection (Passoni et al., 1997). On 
this background, we have examined the mechanism by which 
Aif hypomorphism caused disruption of T cell -selection 
using both genetic and pharmacological tools. Provision of tg 
DNA-binding–deficient mutant Aif rescued the Hq thymic de-
fect, whereas the oxidoreductase-deficient mutant Aif did not 
do so. As noted, because our Aif transgene expression levels do 
not reach those of endogenous Aif, it remains formally possi-
ble that higher levels of expression of the Aif262/299 mutant 
would lead to rescue of the thymic defect. Precise regulation 
of levels of Aif expression in the absence of knockin mice is a 
difficult problem because there is evidence that strong over-
expression of Aif can lead to death of even transfected cell lines 
in culture, possibly as a result of spontaneous leakage of Aif 
from mitochondria (Loeffler et al., 2001; Urbano et al., 2005). 
Instead, we have tried to test the predictions arising from 
the likely requirement for the oxidoreductase function of 
Aif using an independent pharmacological approach with the 
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were washed in PBS and stained with labeled annexin V in annexin V staining 
buffer per manufacturer’s protocols (BD) for 20 min, diluted with staining 
buffer, and analyzed within 30 min of labeling. For DCFDA, CellROX Deep 
Red, MitoSOX red, and mBCl staining, cells were incubated in 5 µM 
DCFDA, 5 µM MitoSOX red, 4 µM mBCl, or 5 µM CellROX Deep 
Red in the dark for 10–30 min (Molecular Probes). Cells were then washed 
and stained for various cell surface markers. Complete medium was added, 
and cells were washed and kept in the dark until analysis. For EdU labeling 
of DNA in proliferating cells, mice were given 100 µg EdU in PBS intraperi-
toneally, and thymocytes were isolated 2 h later. Cells were first stained 
for surface markers, followed by fixation and permeabilization. They were 
then incubated for 30 min at room temperature in staining solution containing 
100 µM Alexa Fluor 488–azide according to the manufacturer’s protocols 
(Invitrogen). For all flow cytometric analyses, samples stained with appropriate 
isotype antibodies served as negative controls.
The antibodies used for staining, either biotinylated or directly cou-
pled to various fluorochromes, as well as fluorochrome-coupled streptavidin, 
were variously sourced (BD; eBioscience). DN1, DN3, and DN4 thymocytes 
were purified by electronic sorting (FACSAria III; BD) as thymocytes 
negative for non–T lineage and mature T lineage markers (CD4, CD8, 
CD3, CD25, CD11b, CD11c, Gr-1, NK1.1, TCR-/, and B220) and 
CD44+CD25 (DN1), CD44CD25+ (DN3), or CD44CD25 (DN4) 
cells. Data acquisition was done either on an LSR (BD) or on a FACSAria I 
or FACSAria III flow cytometer and data analyzed using FlowJo soft-
ware (Tree Star).
In vitro thymocyte development cultures. Thymocytes from Hq mice 
or WT littermates were first negatively selected by staining with biotinylated 
antibodies against CD4, CD8, CD3, CD25, CD11b, CD11c, Gr-1, NK1.1, 
TCR-/, and B220 using magnetic columns (Miltenyi Biotec) to purify 
DN thymocytes. Subsequently, the nonbinding cell population was stained 
with anti-CD44 antibody and positively selected to obtain >95% pure 
CD44+ DN1/DN2 stage thymocytes. The bone marrow stromal cell line 
OP9 expressing the Notch ligand Delta-like 1 was a gift from J.C. Zuniga-
Pflucker (University of Toronto, Canada). OP9-DL1 cells and DN1/DN2 
cells were co-cultured in medium containing 10 ng/ml Flt-3–Ligand and 5 
ng/ml IL-7. The medium was changed gently on day 2 and cytokines were 
replenished. Cells were harvested on day 3 of co-culture and stained for 
Thy-1, CD25, CD44, CD8, and CD4 to track the stage of differentiation by 
flow cytometry.
In vitro thymocyte death assay. WT or Hq DN1, DN3, and DN4 thymo-
cytes purified by electronic sorting were cultured for varying periods of time 
in flat bottomed 96-well plates in DME with 10% FCS with or without 
50 µM Euk-134, and cell death was scored using Trypan blue.
Statistical analyses. Data were analyzed using Student’s t test.
We thank Mr. Inder Jit Singh for extensive help with animal breeding and 
maintenance. We are grateful to Prof. Ranjan Sen for insightful comments on  
the manuscript.
This work was supported in part by grants from the Department of 
Biotechnology (to S. Rath: BT/PR-14592/BRB/10/858/2010; to A. George:  
BT/PR10954/BRB/10/625/2008 and BT/PR12849/MED/15/35/2009; to V. Bal:  
BT/PR-10284/Med/29/59/2007 and BT/PR14420/Med/29/213/2010; to S.S. 
Majumdar: BT/HRD/35/01/01/2010) and the Department of Science and Technology, 
Government of India (to S.S. Majumdar, A. George, V. Bal, and S. Rath), and by the 
National Institutes of Health (to J.M. Durdik; RO3AI070312-01A2) and the Arkansas 
Biosciences Institute (to J.M. Durdik). The National Institute of Immunology is 
supported by the Department of Biotechnology, Government of India.
The authors affirm that they have no conflicts of interest to declare.
Author contributions: H. Banerjee, A. Das, and S. Srivastava helped in planning 
and performed most critical experiments, helped analyze data, helped write the 
manuscript, and share first authorship. H.R. Mattoo, K. Thyagarajan, J.K. Khalsa, and 
Mice. Hq mice (B6CBACa Aw-J/A-Pdcd8Hq/J; The Jackson Laboratory) 
are in a mixed B6xCBA/CaJ background, and hence experiments described 
here have used normal littermates as WT controls. Also, because the aif gene 
is on the X chromosome, hemizygous males, either WT or Hq, were used. 
C57BL/6, B6.SJL, CBA/CaJ, and the DO11.10-TCR tg mice (The Jackson 
Laboratory) were bred in the Small Animal Facility of the National Institute 
of Immunology, New Delhi, India. All animal experiments were done with 
the approval (IAEC 240/10) of the Institutional Animal Ethics Committee 
of the National Institute of Immunology.
For treatment in vivo with the SOD and catalase mimic Euk-134, mice 
were given 10 mg/kg Euk-134 (Cayman Chemical) in normal saline (or nor-
mal saline alone) once daily intraperitoneally for 14 d. On day 15, thymocytes 
were isolated and stained for various cell surface markers for flow cytometry.
For breeding the TCR transgenes onto comparable WT or Hq back-
grounds, TCR tg male mice were mated with homozygous Hq females. The 
F1 progeny were then intercrossed to obtain littermate mice that were WT 
non-TCR tg, Hq non-TCR tg, WT TCR tg, or Hq TCR tg. TCR transgene 
inheritance was confirmed by flow cytometric analysis of peripheral blood for 
the frequency of tg TCR expression in T cells. The Hq allele was typed by ge-
nomic PCR analysis as described by The Jackson Laboratory. Mice were eutha-
nized at 6–8 wk of age for flow cytometric analysis of various tissues.
Mice transgenically expressing WT or mutant Aif were generated by the 
testicular transgenesis method (Dhup and Majumdar, 2008). The transgenes 
were constructed by cloning either the WT mouse aif cDNA sequence, or 
the Aif254/264 or Aif262/300 mutants generated by site-directed mutagen-
esis, into the IRES-eGFP plasmid which uses a CMV promoter (Takara Bio 
Inc.). The linearized plasmid was injected (150 ng/µl) at three separate tes-
ticular sites (10 µl/site) in each testis in anesthetized 4-wk-old FVB/J male 
mice as described. Electroporation was done by administration of eight 
square 40-V electric pulses in with a change in polarity after four pulses with 
a time constant of 0.05 s and an inter-pulse interval of 1 s via an electric 
pulse generator (ECM2001; Harvard Apparatus) using a pair of sterile tweezer-
type electrodes externally. 1 mo after electroporation, the mice were put 
into breeding with FVB/J females. The litters obtained were screened for 
transgene presence by performing PCR with primers designed across the 
IRES (forward primer: 5-CTCTCCTCAAGCGTATTC-3) and eGFP 
(reverse primer: 5-GGACTTGAAGAAGTCGTG-3) sequences of the 
construct. Transgene-expressing male progeny were then used for breeding 
with heterozygous Hq females to obtain male progeny of all four genotypes, 
namely, non-tg WT, tg WT, non-tg Hq, and tg Hq.
Bone marrow chimeras. For generation of mixed bone marrow chimeras, 
F1 mice generated by crossing B6.SJL (CD45.1) with CBA/CaJ (CD45.2) 
were used as recipients. 12 h after irradiation (400 rads with a Co60 source), 
a 1:1 mixture of 20 × 106 bone marrow cells from B6.SJL (CD45.1) mice 
and either WT or Hq mice (CD45.2) was given intravenously. Between 4 
and 8 wk later, frequencies of endogenous and donor repopulating cells were 
scored using CD45.1- and CD45.2-specific markers by flow cytometry.
Flow cytometry. For enumeration of frequencies of CD4 and CD8 cells and 
their activation status, splenic and lymph node cells were stained for multicolor 
analysis for CD4, CD8, and CD44. Proportion of thymic subpopulations was 
analyzed in two-color analyses after staining them for CD4 and CD8. For 
analysis of DN subpopulations in the thymus, a cocktail of biotinylated anti-
bodies followed by labeled streptavidin was used to label and exclude all cells 
which were positive for any one or more of the following markers: CD3, 
CD4, CD8, B220, CD11b, CD11c, Gr-1, NK1.1, and TCR-/. After ex-
clusion of these non-DN thymocytes, the residual DN population was further 
analyzed for CD25 and CD44 frequencies using other fluorophores.
For analysis of bone marrow chimeric mice, cells were stained in multi-
color analyses for CD45.1, CD45.2, and B, T, macrophage, and granulocyte 
markers. For detection of intracellular proteins such as TCR- in DN thymo-
cytes, cells were first stained for various cell surface markers, fixed, and 
permeabilized with 0.03% saponin before being stained with antibodies 
against the intracellular protein targets. For staining with annexin V, cells 
o
n
 February 2, 2017
D
ow
nloaded from
 
Published August 6, 2012
1652 Aif regulates thymic -selection via ROS | Banerjee et al.
Hoffman, E.S., L. Passoni, T. Crompton, T.M. Leu, D.G. Schatz, A. Koff, 
M.J. Owen, and A.C. Hayday. 1996. Productive T-cell receptor -chain 
gene rearrangement: coincident regulation of cell cycle and clonality 
during development in vivo. Genes Dev. 10:948–962. http://dx.doi.org/ 
10.1101/gad.10.8.948
Ishimura, R., G.R. Martin, and S.L. Ackerman. 2008. Loss of apoptosis-inducing 
factor results in cell-type-specific neurogenesis defects. J. Neurosci. 28: 
4938–4948. http://dx.doi.org/10.1523/JNEUROSCI.0229-08.2008
Ivanov, V., M. Merkenschlager, and R. Ceredig. 1993. Antioxidant treatment 
of thymic organ cultures decreases NF-kappa B and TCF1() transcrip-
tion factor activities and inhibits   T cell development. J. Immunol. 
151:4694–4704.
Izquierdo, M., A. Grandien, L.M. Criado, S. Robles, E. Leonardo, J.P. Albar, 
G.G. de Buitrago, and C. Martínez-A. 1999. Blocked negative selection of 
developing T cells in mice expressing the baculovirus p35 caspase inhibi-
tor. EMBO J. 18:156–166. http://dx.doi.org/10.1093/emboj/18.1.156
Joza, N., S.A. Susin, E. Daugas, W.L. Stanford, S.K. Cho, C.Y. Li, T. 
Sasaki, A.J. Elia, H.Y. Cheng, L. Ravagnan, et al. 2001. Essential role of 
the mitochondrial apoptosis-inducing factor in programmed cell death. 
Nature. 410:549–554. http://dx.doi.org/10.1038/35069004
Joza, N., G.Y. Oudit, D. Brown, P. Bénit, Z. Kassiri, N. Vahsen, L. Benoit, M.M. 
Patel, K. Nowikovsky, A. Vassault, et al. 2005. Muscle-specific loss of 
apoptosis-inducing factor leads to mitochondrial dysfunction, skeletal 
muscle atrophy, and dilated cardiomyopathy. Mol. Cell. Biol. 25:10261–
10272. http://dx.doi.org/10.1128/MCB.25.23.10261-10272.2005
Joza, N., J.A. Pospisilik, E. Hangen, T. Hanada, N. Modjtahedi, J.M. 
Penninger, and G. Kroemer. 2009. AIF: not just an apoptosis-inducing 
factor. Ann. N. Y. Acad. Sci. 1171:2–11. http://dx.doi.org/10.1111/
j.1749-6632.2009.04681.x
Kitamura, D., A. Kudo, S. Schaal, W. Müller, F. Melchers, and K. Rajewsky. 
1992. A critical role of lambda 5 protein in B cell development. Cell. 
69:823–831. http://dx.doi.org/10.1016/0092-8674(92)90293-L
Klein, J.A., C.M. Longo-Guess, M.P. Rossmann, K.L. Seburn, R.E. Hurd, 
W.N. Frankel, R.T. Bronson, and S.L. Ackerman. 2002. The harlequin 
mouse mutation downregulates apoptosis-inducing factor. Nature. 419: 
367–374. http://dx.doi.org/10.1038/nature01034
Loeffler, M., E. Daugas, S.A. Susin, N. Zamzami, D. Metivier, A.L.  
Nieminen, G. Brothers, J.M. Penninger, and G. Kroemer. 2001. Dominant 
cell death induction by extramitochondrially targeted apoptosis-
 inducing factor. FASEB J. 15:758–767. http://dx.doi.org/10.1096/ 
fj.00-0388com
Maté, M.J., M. Ortiz-Lombardía, B. Boitel, A. Haouz, D. Tello, S.A. Susin, 
J. Penninger, G. Kroemer, and P.M. Alzari. 2002. The crystal struc-
ture of the mouse apoptosis-inducing factor AIF. Nat. Struct. Biol. 9: 
442–446. http://dx.doi.org/10.1038/nsb793
Michie, A.M., and J.C. Zúñiga-Pflücker. 2002. Regulation of thymocyte 
differentiation: pre-TCR signals and -selection. Semin. Immunol. 14: 
311–323. http://dx.doi.org/10.1016/S1044-5323(02)00064-7
Moon, E.-Y., Y.H. Han, D.-S. Lee, Y.-M. Han, and D.-Y. Yu. 2004. 
Reactive oxygen species induced by the deletion of peroxiredoxin II 
(PrxII) increases the number of thymocytes resulting in the enlargement 
of PrxII-null thymus. Eur. J. Immunol. 34:2119–2128. http://dx.doi.org/ 
10.1002/eji.200424962
Nishimura, H., T. Honjo, and N. Minato. 2000. Facilitation of  selection and 
modification of positive selection in the thymus of PD-1–deficient mice. 
J. Exp. Med. 191:891–898. http://dx.doi.org/10.1084/jem.191.5.891
Passoni, L., E.S. Hoffman, S. Kim, T. Crompton, W. Pao, M.Q. Dong, 
M.J. Owen, and A.C. Hayday. 1997. Intrathymic delta selection events 
in gammadelta cell development. Immunity. 7:83–95. http://dx.doi.org/ 
10.1016/S1074-7613(00)80512-9
Pospisilik, J.A., C. Knauf, N. Joza, P. Benit, M. Orthofer, P.D. Cani, I. 
Ebersberger, T. Nakashima, R. Sarao, G. Neely, et al. 2007. Targeted 
deletion of AIF decreases mitochondrial oxidative phosphorylation and 
protects from obesity and diabetes. Cell. 131:476–491. http://dx.doi 
.org/10.1016/j.cell.2007.08.047
Schmitt, T.M., and J.C. Zúñiga-Pflücker. 2002. Induction of T cell develop-
ment from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity. 
17:749–756. http://dx.doi.org/10.1016/S1074-7613(02)00474-0
S. Tanwar helped in planning and performed some critical experiments and  
helped analyze some data and write the manuscript. S.S. Majumdar and  
D.S. Das planned and performed critical experiments requiring key technology 
and expertise. A. George, V. Bal, J.M. Durdik, and S. Rath conceived the question and 
approach, planned experiments, analyzed data, wrote the manuscript, and share 
senior authorship.
Submitted: 9 February 2011
Accepted: 20 July 2012
REFERENCES
Bidère, N., and A. Senik. 2001. Caspase-independent apoptotic pathways in 
T lymphocytes: a minireview. Apoptosis. 6:371–375. http://dx.doi.org/ 
10.1023/A:1011390103783
Candé, C., F. Cecconi, P. Dessen, and G. Kroemer. 2002. Apoptosis-
 inducing factor (AIF): key to the conserved caspase-independent 
pathways of cell death? J. Cell Sci. 115:4727–4734. http://dx.doi.org/ 
10.1242/jcs.00210
Cheung, E.C.C., N. Joza, N.A.E. Steenaart, K.A. McClellan, M. Neuspiel, 
S. McNamara, J.G. MacLaurin, P. Rippstein, D.S. Park, G.C. Shore, 
et al. 2006. Dissociating the dual roles of apoptosis-inducing factor in 
maintaining mitochondrial structure and apoptosis. EMBO J. 25:4061–
4073. http://dx.doi.org/10.1038/sj.emboj.7601276
Cho, B.K., V.P. Rao, Q. Ge, H.N. Eisen, and J. Chen. 2000. Homeostasis-
stimulated proliferation drives naive T cells to differentiate directly into 
memory T cells. J. Exp. Med. 192:549–556. http://dx.doi.org/10.1084/ 
jem.192.4.549
Cleverley, S., S. Henning, and D. Cantrell. 1999. Inhibition of Rho at 
different stages of thymocyte development gives different perspec-
tives on Rho function. Curr. Biol. 9:657–660. http://dx.doi.org/10 
.1016/S0960-9822(99)80289-9
Costello, P.S., S.C. Cleverley, R. Galandrini, S.W. Henning, and D.A. 
Cantrell. 2000. The GTPase rho controls a p53-dependent survival check-
point during thymopoiesis. J. Exp. Med. 192:77–85. http://dx.doi.org/ 
10.1084/jem.192.1.77
Dhup, S., and S.S. Majumdar. 2008. Transgenesis via permanent integra-
tion of genes in repopulating spermatogonial cells in vivo. Nat. Methods. 
5:601–603. http://dx.doi.org/10.1038/nmeth.1225
Doctrow, S.R., K. Huffman, C.B. Marcus, G. Tocco, E. Malfroy, C.A. 
Adinolfi, H. Kruk, K. Baker, N. Lazarowych, J. Mascarenhas, and B. 
Malfroy. 2002. Salen-manganese complexes as catalytic scavengers of 
hydrogen peroxide and cytoprotective agents: structure-activity re-
lationship studies. J. Med. Chem. 45:4549–4558. http://dx.doi.org/ 
10.1021/jm020207y
Doerfler, P., K.A. Forbush, and R.M. Perlmutter. 2000. Caspase enzyme 
activity is not essential for apoptosis during thymocyte development. 
J. Immunol. 164:4071–4079.
Dudley, E.C., H.T. Petrie, L.M. Shah, M.J. Owen, and A.C. Hayday. 1994. 
T cell receptor  chain gene rearrangement and selection during thymo-
cyte development in adult mice. Immunity. 1:83–93. http://dx.doi.org/ 
10.1016/1074-7613(94)90102-3
Ferri, K.F., E. Jacotot, J. Blanco, J.A. Esté, N. Zamzami, S.A. Susin, Z. 
Xie, G. Brothers, J.C. Reed, J.M. Penninger, and G. Kroemer. 2000. 
Apoptosis control in syncytia induced by the HIV type 1–envelope 
glycoprotein complex: role of mitochondria and caspases. J. Exp. Med. 
192:1081–1092. http://dx.doi.org/10.1084/jem.192.8.1081
Ghezzi, D., I. Sevrioukova, F. Invernizzi, C. Lamperti, M. Mora, P. 
D’Adamo, F. Novara, O. Zuffardi, G. Uziel, and M. Zeviani. 2010. 
Severe X-linked mitochondrial encephalomyopathy associated with a 
mutation in apoptosis-inducing factor. Am. J. Hum. Genet. 86:639–649. 
http://dx.doi.org/10.1016/j.ajhg.2010.03.002
Hedley, D.W., and S. Chow. 1994. Evaluation of methods for measuring 
cellular glutathione content using flow cytometry. Cytometry. 15:349–
358. http://dx.doi.org/10.1002/cyto.990150411
Hildeman, D.A. 2004. Regulation of T-cell apoptosis by reactive oxy-
gen species. Free Radic. Biol. Med. 36:1496–1504. http://dx.doi.org/ 
10.1016/j.freeradbiomed.2004.03.023
o
n
 February 2, 2017
D
ow
nloaded from
 
Published August 6, 2012
JEM Vol. 209, No. 9 
Article
1653
Schmitt, T.M., M. Ciofani, H.T. Petrie, and J.C. Zúñiga-Pflücker. 2004. 
Maintenance of T cell specification and differentiation requires recur-
rent notch receptor-ligand interactions. J. Exp. Med. 200:469–479. 
http://dx.doi.org/10.1084/jem.20040394
Schulthess, F.T., S. Katz, A. Ardestani, H. Kawahira, S. Georgia, D. Bosco, 
A. Bhushan, and K. Maedler. 2009. Deletion of the mitochondrial fla-
voprotein apoptosis inducing factor (AIF) induces -cell apoptosis and 
impairs -cell mass. PLoS ONE. 4:e4394. http://dx.doi.org/10.1371/
journal.pone.0004394
Sevrioukova, I.F. 2011. Apoptosis-inducing factor: structure, function, and 
redox regulation. Antioxid. Redox Signal. 14:2545–2579. http://dx.doi.org/ 
10.1089/ars.2010.3445
Srivastava, S., H. Banerjee, A. Chaudhry, A. Khare, A. Sarin, A. George, V. 
Bal, J.M. Durdik, and S. Rath. 2007. Apoptosis-inducing factor regu-
lates death in peripheral T cells. J. Immunol. 179:797–803.
Strasser, A., and P. Bouillet. 2003. The control of apoptosis in lymphocyte 
selection. Immunol. Rev. 193:82–92. http://dx.doi.org/10.1034/j.1600-
065X.2003.00036.x
Sun, Z., D. Unutmaz, Y.R. Zou, M.J. Sunshine, A. Pierani, S. Brenner-Morton, 
R.E. Mebius, and D.R. Littman. 2000. Requirement for RORgamma 
in thymocyte survival and lymphoid organ development. Science. 
288:2369–2373. http://dx.doi.org/10.1126/science.288.5475.2369
Taghon, T., M.A. Yui, R. Pant, R.A. Diamond, and E.V. Rothenberg. 
2006. Developmental and molecular characterization of emerging - and 
gammadelta-selected pre-T cells in the adult mouse thymus. Immunity. 
24:53–64. http://dx.doi.org/10.1016/j.immuni.2005.11.012
Thompson, L.F., J.G. Vaughn, A.B. Laurent, M.R. Blackburn, and C.J. 
Van De Wiele. 2003. Mechanisms of apoptosis in developing thymo-
cytes as revealed by adenosine deaminase-deficient fetal thymic organ 
cultures. Biochem. Pharmacol. 66:1595–1599. http://dx.doi.org/10.1016/ 
S0006-2952(03)00530-6
Trigueros, C., K. Hozumi, B. Silva-Santos, L. Bruno, A.C. Hayday, M.J. 
Owen, and D.J. Pennington. 2003. Pre-TCR signaling regulates IL-7 
receptor  expression promoting thymocyte survival at the transition 
from the double-negative to double-positive stage. Eur. J. Immunol. 33: 
1968–1977. http://dx.doi.org/10.1002/eji.200323831
Urbano, A., U. Lakshmanan, P.H. Choo, J.C. Kwan, P.Y. Ng, K. Guo, S. 
Dhakshinamoorthy, and A. Porter. 2005. AIF suppresses chemical 
stress-induced apoptosis and maintains the transformed state of tumor 
cells. EMBO J. 24:2815–2826. http://dx.doi.org/10.1038/sj.emboj 
.7600746
Vahsen, N., C. Candé, J.-J. Brière, P. Bénit, N. Joza, N. Larochette, P.G. 
Mastroberardino, M.O. Pequignot, N. Casares, V. Lazar, et al. 2004. 
AIF deficiency compromises oxidative phosphorylation. EMBO J. 23: 
4679–4689. http://dx.doi.org/10.1038/sj.emboj.7600461
Van De Wiele, C.J., J.G. Vaughn, M.R. Blackburn, C.A. Ledent, M. 
Jacobson, H. Jiang, and L.F. Thompson. 2002. Adenosine kinase 
inhibition promotes survival of fetal adenosine deaminase-deficient 
thymocytes by blocking dATP accumulation. J. Clin. Invest. 110: 
395–402.
Vig, M., S. Srivastava, U. Kandpal, H. Sade, V. Lewis, A. Sarin, A. George, 
V. Bal, J.M. Durdik, and S. Rath. 2004. Inducible nitric oxide synthase 
in T cells regulates T cell death and immune memory. J. Clin. Invest. 
113:1734–1742.
Wiest, D.L., M.A. Berger, and M. Carleton. 1999. Control of early thy-
mocyte development by the pre-T cell receptor complex: A receptor 
without a ligand? Semin. Immunol. 11:251–262. http://dx.doi.org/ 
10.1006/smim.1999.0181
Ye, H., C. Cande, N.C. Stephanou, S. Jiang, S. Gurbuxani, N. Larochette, 
E. Daugas, C. Garrido, G. Kroemer, and H. Wu. 2002. DNA binding 
is required for the apoptogenic action of apoptosis inducing factor. Nat. 
Struct. Biol. 9:680–684. http://dx.doi.org/10.1038/nsb836
o
n
 February 2, 2017
D
ow
nloaded from
 
Published August 6, 2012
